SCHEDULE: Divisadero Street Capital Reports 0.5% Stake in RxSight

Divisadero Street Capital Management and related entities disclose a 0.5% beneficial ownership stake in RxSight, Inc. common stock.

Summary

• Divisadero Street Capital Management, LP, William Zolezzi, Divisadero Street Partners, L.P., Divisadero Street Partners GP, LLC, and Divisadero Street Capital, LLC collectively reported beneficial ownership of 218,918 shares of RxSight, Inc. common stock.
• This aggregate ownership represents 0.5% of RxSight, Inc.'s outstanding common stock.
• All reporting persons share voting and dispositive power over the 218,918 shares, with no sole voting or dispositive power reported.
• The filing is an Amendment No. 1 to a Schedule 13G, indicating a previous filing for this ownership group.
• The securities were certified as not acquired or held for the purpose of changing or influencing control of RxSight, Inc.

Sentiment

Score: 5

Explanation: This is a factual disclosure of beneficial ownership and does not contain information that would inherently indicate positive or negative sentiment regarding the company's performance or outlook.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: Provides transparency regarding institutional ownership, though the reported stake is minor (0.5%).

Key Dates

Keywords

RxSight, Divisadero Street Capital Management, Beneficial Ownership, SEC Filing, Schedule 13G, Common Stock, Institutional Investor, Equity Stake